Outside Yellowknife, please call your local health centre
Starting May 1, 2023 appointments for COVID-19 Vaccine will be available at Yellowknife Public Health Office at the Jan Stirling Building at 4702 Franklin Avenue (https://goo.gl/maps/qf46zu5WKAgvqkgE8).
For all immunization appointments, including the COVID-19 vaccine and Monkeypox vaccine, residents can call Yellowknife Public Health at (867) 767-9120.
Eligibility for the COVID-19 vaccine is based on an individual’s age and medical conditions. Check below to see which doses you are eligible for, then call Yellowknife Public Health or your local health centre to book a vaccine appointment. At the time of your appointment, tell your healthcare provider if you are immunocompromised or have a condition that puts you at higher risk of severe outcome for COVID-19; you may need a larger dose of the vaccine.
The following groups are eligible for a first and second dose:
- All people aged 6 months of age and older
- Eligibility will be based on age at the time of appointment. If your child is not at least 6 months of age at the time of the appointment, they will not be able to receive the vaccine.
When: First and second doses are typically given as a series. There are different time periods you should wait between doses, depending on which vaccine you receive. The below chart outlines recommended timing between the first and second dose for different brands of the vaccine.
Access to COVID-19 booster doses is currently available territory-wide. You are eligible if:
- It has been six months since your last dose
- It has been at least 6 months since COVID infection
- You are 5 years of age or older
Starting in the spring of 2023, NACI recommends that an additional booster dose may be offered as per the recommended interval* to the following individuals who are at increased risk of severe illness from COVID-19:
- Adults 80 years of age and older
- Adult residents of long-term care homes and other congregate living settings for seniors or those with complex medical care needs
- Adults 18 years of age and older who are moderately to severely immunocompromised (due to an underlying condition or treatment)
- Adults 65 to 79 years of age, particularly if they do not have a known prior history of SARS-CoV-2 infection**
* The recommended interval is 6 or more months from the last COVID-19 vaccine dose or SARS-CoV-2 infection if applicable (whichever is longer). It should be noted that vaccination with shorter intervals between previous vaccination or infection has not been shown to pose a safety risk, though evidence shows that the antibody response is higher with longer intervals between infection and vaccination and with longer intervals between vaccination doses.
** Previous infection can be defined in different ways based on jurisdictional policies and access to testing. The following suggestion can be considered to define previous infection with SARS-CoV-2:
- Confirmed by a molecular (e.g., PCR) or Health Canada-approved antigen detection-based test; or
- Symptomatic disease compatible with COVID-19 AND household exposure to a confirmed COVID-19 case.
Recommended that doses 1 & 2 be given 3 to 16 weeks apart
This vaccine is approved for people 5 years of age and older.
Recommended that doses 1 & 2 be given 4 to 16 weeks apart. Dose spacing for 6 month to 5 years is currently recommended at 8 weeks.
This vaccine is approved for people 6 months of age and older.
Recommended that doses be given 8 weeks apart, at a minimum of 21 days after first dose.
This vaccine is approved for people 18 years of age and older.
If a second dose is delayed past the recommended time frame, the second dose should still be given as soon as possible. You do not have to restart the vaccine series if this happens.
Eligibility for the COVID-19 vaccine is based on an individual’s age and medical conditions. Often booster doses are available earlier to individuals who are immunocompromised.
An individual would be considered to have moderate to severe immune compromise if they have one of the following conditions or treatments:
- Active treatment of cancer or other hematologic malignancy
- Recipient of solid-organ transplant and taking immunosuppressive therapy
- Treatment of leukemia with T cell therapy, or had a stem cell transplant within the last two years
- Moderate to severe primary B or T cell immunodeficiency (e.g.: Di George Syndrome or Wiskott-Alrich Syndrome)
- Stage 3 or advanced untreated HIV infection or diagnosis of Acquired Immune Deficiency Syndrome (AIDS)
- Active treatment of active disease (neurological, autoimmune, neoplastic) with any of the following immune suppressive therapies:
- Corticosteroids at doses equivalent to or greater than prednisone 20mg/day for greater than 14 days
- Anti-B cell therapy (e.g.: rituximab/Rituxan, belimumab/Benlysta, etanercept/Enbrel, tocilizumab/Actemra)
- Alkylating agent therapy (e.g.: carboplatin, chlorambucil, cisplatin, cyclophosphamide)
- Systemic antimetabolite therapy (e.g.: 6-mercaptopurine, 5-fluorouracil, gemcitabine, cytarabine, pemetrexed, methotrexate)
- Tumour necrosis factor (TNF) inhibitor therapy (e.g.: infliximab/Remicade, etanercept/Enbrel, adalimumab/Humira)
- Other biologic therapy (e.g.: ustekinumab/Stelara)
If you believe you have moderate to severe immune compromise and your situation is not represented in this list, talk your healthcare provider about whether your condition makes you eligible for a 3rd or 4th dose of the COVID-19 vaccine.
A self-service online form is available to individuals five and older, and allows you to immediately download your digital proof of vaccine credential. You can use this government-issued credential to prove your COVID-19 vaccination status where required.
If you previously requested a copy of your COVID-19 medical record proof it is still valid proof of vaccination, but it will not be able to be scanned and verified because it does not have QR code.
If you are unable to successfully use the self-service form or do not have access to a computer, you can request a printed copy at your local health centre.
The Proof of Vaccination Credential (PVC) Office in Yellowknife is closed as of May 1st, 2022. PVC services can still be accessed at Public Health or by email at NTHSSA_covidvaxrecords@gov.nt.ca
If you are having difficulties downloading your PVC, please email NTHSSA_covidvaxrecords@gov.nt.ca with the following information:
- Scanned copy of your NWT Healthcare Card – must be valid and not expired
- Scanned copy of your government-issued photo ID
- Any out-of-territory documents or record of immunization, in order to validate, that include:
- First and last name
- Date of vaccination
- Community and Province/Territory of vaccination
- Vaccine name and lot number
- Size of dose administered
- Where on your body you received the vaccination